Juno Therapeutics (Germany)
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
51
Total Open
Publications
29
Total
Citations
2.2K
Open Access
Percentage
57%
Total
Publications
51
Total Open
Publications
29
Total
Citations
2.2K
Breakdown
Publisher Open
20%
Both
21%
Other Platform Open
16%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
10
Hybrid 28%
6
No Guarantees 24%
5
Other Platform Open
Domain 53%
10
Institution 42%
8
Preprint 26%
5
Public 5%
1
Other Internet 5%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 10 |
bioRxiv | Preprint | 4 |
Technical University of Munich | Institution | 3 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Universidade Estadual Paulista (Unesp) | Institution | 1 |
Saints Cyril and Methodius University of Skopje | Institution | 1 |
Research Square | Preprint | 1 |
Ludwig-Maximilians-Universität München | Institution | 1 |
Harvard University | Institution | 1 |